Cargando…
Rapidly evolving Creutzfeldt–Jakob disease in COVID-19: from early status epilepticus to fatal outcome
We report the case of a 70-year-old man coming to our attention for new onset refractory status epilepticus (NORSE) in a rapidly evolving CJD during SARS-CoV-2 co-infection. Our case report describes a fulminant CJD evolution associated with SARS-CoV-2 infection, which led to patient death after 15 ...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294798/ https://www.ncbi.nlm.nih.gov/pubmed/35852764 http://dx.doi.org/10.1007/s13760-022-02023-x |
_version_ | 1784749922342404096 |
---|---|
author | Olivo, Sasha Furlanis, Giovanni Buoite Stella, Alex Fabris, Martina Milanic, Romina Zanusso, Gianluigi Manganotti, Paolo |
author_facet | Olivo, Sasha Furlanis, Giovanni Buoite Stella, Alex Fabris, Martina Milanic, Romina Zanusso, Gianluigi Manganotti, Paolo |
author_sort | Olivo, Sasha |
collection | PubMed |
description | We report the case of a 70-year-old man coming to our attention for new onset refractory status epilepticus (NORSE) in a rapidly evolving CJD during SARS-CoV-2 co-infection. Our case report describes a fulminant CJD evolution associated with SARS-CoV-2 infection, which led to patient death after 15 days from admission. First EEG presented continuous diffuse spikes, sharp waves and sharp-and-slow wave complexes, pattern consistent with a non-convulsive status epilepticus (NORSE). Our case supports how CJD with SARS-CoV-2 co-infection could be characterized by an accelerated evolution, as already hypothesize for others microorganism infections, and how the diagnosis might be more challenging due to its uncommon presentations, such as NORSE. |
format | Online Article Text |
id | pubmed-9294798 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-92947982022-07-19 Rapidly evolving Creutzfeldt–Jakob disease in COVID-19: from early status epilepticus to fatal outcome Olivo, Sasha Furlanis, Giovanni Buoite Stella, Alex Fabris, Martina Milanic, Romina Zanusso, Gianluigi Manganotti, Paolo Acta Neurol Belg Letter to the Editor We report the case of a 70-year-old man coming to our attention for new onset refractory status epilepticus (NORSE) in a rapidly evolving CJD during SARS-CoV-2 co-infection. Our case report describes a fulminant CJD evolution associated with SARS-CoV-2 infection, which led to patient death after 15 days from admission. First EEG presented continuous diffuse spikes, sharp waves and sharp-and-slow wave complexes, pattern consistent with a non-convulsive status epilepticus (NORSE). Our case supports how CJD with SARS-CoV-2 co-infection could be characterized by an accelerated evolution, as already hypothesize for others microorganism infections, and how the diagnosis might be more challenging due to its uncommon presentations, such as NORSE. Springer International Publishing 2022-07-19 /pmc/articles/PMC9294798/ /pubmed/35852764 http://dx.doi.org/10.1007/s13760-022-02023-x Text en © The Author(s) under exclusive licence to Belgian Neurological Society 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Letter to the Editor Olivo, Sasha Furlanis, Giovanni Buoite Stella, Alex Fabris, Martina Milanic, Romina Zanusso, Gianluigi Manganotti, Paolo Rapidly evolving Creutzfeldt–Jakob disease in COVID-19: from early status epilepticus to fatal outcome |
title | Rapidly evolving Creutzfeldt–Jakob disease in COVID-19: from early status epilepticus to fatal outcome |
title_full | Rapidly evolving Creutzfeldt–Jakob disease in COVID-19: from early status epilepticus to fatal outcome |
title_fullStr | Rapidly evolving Creutzfeldt–Jakob disease in COVID-19: from early status epilepticus to fatal outcome |
title_full_unstemmed | Rapidly evolving Creutzfeldt–Jakob disease in COVID-19: from early status epilepticus to fatal outcome |
title_short | Rapidly evolving Creutzfeldt–Jakob disease in COVID-19: from early status epilepticus to fatal outcome |
title_sort | rapidly evolving creutzfeldt–jakob disease in covid-19: from early status epilepticus to fatal outcome |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294798/ https://www.ncbi.nlm.nih.gov/pubmed/35852764 http://dx.doi.org/10.1007/s13760-022-02023-x |
work_keys_str_mv | AT olivosasha rapidlyevolvingcreutzfeldtjakobdiseaseincovid19fromearlystatusepilepticustofataloutcome AT furlanisgiovanni rapidlyevolvingcreutzfeldtjakobdiseaseincovid19fromearlystatusepilepticustofataloutcome AT buoitestellaalex rapidlyevolvingcreutzfeldtjakobdiseaseincovid19fromearlystatusepilepticustofataloutcome AT fabrismartina rapidlyevolvingcreutzfeldtjakobdiseaseincovid19fromearlystatusepilepticustofataloutcome AT milanicromina rapidlyevolvingcreutzfeldtjakobdiseaseincovid19fromearlystatusepilepticustofataloutcome AT zanussogianluigi rapidlyevolvingcreutzfeldtjakobdiseaseincovid19fromearlystatusepilepticustofataloutcome AT manganottipaolo rapidlyevolvingcreutzfeldtjakobdiseaseincovid19fromearlystatusepilepticustofataloutcome |